Comparison

Human HER2 Monoclonal Antibody, Endotoxin 0.05 EU/mg European Partner

Item no. YR0042-5mg
Manufacturer Abclonal
Amount 5 mg
Quantity options 20 mg 5 mg
Category
Applications ELISA, FA, NT
Specific against other
Isotype IgG1 Kappa
Purity >95% Determined by SDS-PAGE
NCBI HER2
Alias NEU,NGL,ERBB2,TKR1,CD340,HER-2,VSCN2,MLN 19,MLN-19,c-ERB2,c-ERB-2,HER-2/neu,p185(erbB2)
Available
Manufacturer - Applications
ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways
Manufacturer - Category
Biosimilar
Manufacturer - Conjugate / Tag
<5% Determined by SECP
Storage Conditions
2 - 8°C for up to 4 weeks and -80°C for long term storage (Avoid repeated freezing and thawing)
Background
Pertuzumab, a humanized monoclonal antibody, inhibits HER dimerization and is used for the treatment of HER2-positive metastatic breast cancer, in combination with trastuzumab and docetaxel. By binding to HER2, Pertuzumab inhibits the dimerization of HER2 with other HER receptors, resulting in slowed tumor growth.
Manufacturer - Cross Reactivity
<0.05EU/mg (<0.00005EU/μg)Determined by LAL gel clotting assay
Immunogen
Human ErbB-2 / Her2
Recommended Dilution
In Vivo Grade Recombinant Human IgG1 Kappa Isotype Control Antibody
Route
1×PBS pH 7.0
Manufacturer - Research Area
Cancer immunology
Gene Symbol
HER2

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close